Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Argenx Se ADR
(NQ:
ARGX
)
565.00
+21.16 (+3.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Argenx Se ADR
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
What 20 Analyst Ratings Have To Say About argenx
August 31, 2023
Via
Benzinga
Here's How Much $1000 Invested In argenx 5 Years Ago Would Be Worth Today
August 30, 2023
Via
Benzinga
argenx to Present at Upcoming Investor Conferences
August 30, 2023
From
argenx SE
Via
GlobeNewswire
Top AI Stock ANET Leads 5 Stocks Near Buy Points In Tough Market
August 19, 2023
Arista Networks and Dutch biotech Argenx lead this weekend's watch list.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
August 10, 2023
Via
Benzinga
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today
July 31, 2023
Via
Benzinga
Is Argenx Stock a Buy Now?
July 31, 2023
Good news keeps rolling in for the biotech.
Via
The Motley Fool
Earnings Outlook For argenx
July 26, 2023
Via
Benzinga
argenx Unusual Options Activity
July 21, 2023
Via
Benzinga
Why Shares of Argenx Jumped This Week
July 21, 2023
The company's lead therapy showed progress in treating an autoimmune disorder.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Via
Benzinga
argenx Reports Half Year 2023 Financial Results and Provides Second Quarter Business Update
July 27, 2023
From
argenx SE
Via
GlobeNewswire
The Latest Analyst Ratings for argenx
July 20, 2023
Via
Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today
July 18, 2023
Via
Benzinga
Why Argenx Stock Is on Fire Today
July 17, 2023
A major clinical win is boosting the drugmaker's shares today.
Via
The Motley Fool
Argenx Stock Rides 'Megabuster' Drug Excitement To 40% Gain Before Earnings
July 26, 2023
Argenx is up around 40% in 2023 after shares soared nearly 30% in a single day last week.
Via
Investor's Business Daily
argenx announces closing of global offering
July 24, 2023
From
argenx SE
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
July 24, 2023
Via
Benzinga
Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review
July 21, 2023
But all the major indexes are at or near 15-month highs.
Via
Investor's Business Daily
Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade
July 20, 2023
On Thursday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, from 78 to 81.
Via
Investor's Business Daily
argenx to Report Half Year 2023 Financial Results and Second Quarter Business Update on July 27, 2023
July 20, 2023
From
argenx SE
Via
GlobeNewswire
argenx announces full exercise of underwriters’ option to purchase additional ADSs
July 19, 2023
From
argenx SE
Via
GlobeNewswire
argenx raises $1.1 billion in gross proceeds in a global offering
July 18, 2023
From
argenx SE
Via
GlobeNewswire
Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development
July 18, 2023
Monday, Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory demyelinating...
Via
Benzinga
argenx announces launch of proposed global offering
July 17, 2023
From
argenx SE
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
July 17, 2023
Via
Benzinga
argenx SE (NASDAQ: ARGX) Leading the Way in Monday Trading Based on Percentage Gain
July 17, 2023
Via
Investor Brand Network
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...
Via
Benzinga
Argenx Catapults 27% To Record High As It Edges Closer To A New Multibillion-Dollar Market
July 17, 2023
Vyvgart is already approved in multiple diseases. But Argenx isn't stopping there.
Via
Investor's Business Daily
You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers
July 17, 2023
Big gains are afoot even as the markets prepare for a flat open.
Via
The Motley Fool
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.